Rocket Pharmaceuticals, Inc. (RCKT) Social Stream



Rocket Pharmaceuticals, Inc. (RCKT): $18.46

-0.75 (-3.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RCKT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 378

in industry

ROCKET PHARMACEUTICALS INC (RCKT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RCKT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-14 10 $75 $56 $66.75 $18.39 262.97%
2021-12-15 10 $75 $60 $66.142 $18.39 259.66%
2022-01-28 9 $75 $60 $66.142 $18.39 259.66%
2022-02-01 9 $75 $60 $65.428 $18.39 255.78%
2022-02-24 8 $69 $60 $63.833 $18.39 247.11%
2022-02-25 7 $67 $60 $63 $18.39 242.58%
2022-04-25 7 $67 $57 $62.166 $18.39 238.04%
2022-05-06 8 $67 $57 $62.166 $18.39 238.04%
2022-05-09 8 $67 $30 $55 $18.39 199.08%
2022-05-19 9 $67 $30 $56.714 $18.39 208.4%
2022-05-21 9 $67 $30 $57.285 $18.39 211.5%
2022-06-08 9 $67 $30 $56 $18.39 204.51%
2022-08-09 10 $67 $22 $50.125 $18.39 172.57%
2022-09-17 10 $67 $24 $52.125 $18.39 183.44%
2022-09-20 10 $67 $24 $52 $18.39 182.76%
2022-09-27 11 $67 $24 $53.333 $18.39 190.01%
2022-09-30 12 $75 $24 $55.5 $18.39 201.79%
2022-10-03 12 $75 $34 $56.5 $18.39 207.23%
2022-10-06 12 $75 $34 $56.8 $18.39 208.86%
2022-10-12 12 $75 $34 $56.3 $18.39 206.14%
2022-10-24 11 $75 $34 $55.9 $18.39 203.97%
2022-11-01 12 $75 $34 $54 $18.39 193.64%
2022-11-04 12 $75 $34 $53.909 $18.39 193.14%
2022-11-07 12 $75 $33 $53.818 $18.39 192.65%
2022-11-08 13 $75 $33 $53.583 $18.39 191.37%

The Trend in the Analyst Price Target


RCKT's average price target has moved down $16.92 over the prior 21 months.

RCKT reports an average of 298.52% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-28 9 75 60 66.142 15.77 319.42%
2022-05-21 9 67 30 57.285 10.70 435.37%
2022-08-09 10 67 24 52.000 16.23 220.39%
2022-08-16 10 67 24 52.125 17.93 190.71%
2022-10-03 12 75 34 56.800 15.50 266.45%

RCKT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.15 11 2 0 0 0 13

The Trend in the Broker Recommendations


Over the past 48 weeks, RCKT's average broker recommendation rating worsened by 0.07.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ROCKET PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 2507.21% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, ROCKET PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1697.34% of them.
  • RCKT has a greater number of analysts covering the stock than 2293.59% of Pharmaceutical Products stocks.
  • RCKT has a greater average analyst price target than 2230.08% of Pharmaceutical Products stocks.

Stocks similar to ROCKET PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AKTX, AMTI, and CERE.

Make investment decisions regarding RCKT using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8811 seconds.